Crystal structures of bis(AZIDO)bis(2-morpholin-4-ylethylamino)copper(II) and bis{2,4-dibromo-6-[(2-morpholin-4-ylethylimino)methyl] phenolato}copper(II)

Two new copper(II) complexes [Cu(MEA)₂(N₃)₂] (1) and [Cu(BMP)₂] (2), where MEA and BMP are 2-morpholin-4-ylethylamine and 2,4-dibromo-6-[(2-morpholin-4-ylethylimino)methyl]phenolate respectively, are prepared and characterized using elemental analysis, FT-IR spectroscopy, and X-ray single crystal diffraction. The crystal of 1 belongs to the triclinic system, space group P-1, with a = 6.661(2) Å, b = 8.440(3) Å, c = 8.913(3) Å, α = 102.032(3)°, β = 107.899(2)°, γ = 98.242(3)°, V = 454.6(3) ų, Z = 1, D _c = 1.490 g/cm³, R ₁ = 0.0226, and wR ₂ = 0.0564. The crystal of 2 belongs to the monoclinic system, space group P2₁/c, with α = 7.0707(7) Å, b = 15.438(1) Å, c = 14.227(1) Å, β = 96.659(2)°, V = 1542.5(3) ų, Z = 2, D _c = 1.821 g/cm³, R ₁ = 0.0437, and wR ₂ = 0.1041. In each complex, the Cu atom is in a square planar coordination. The molecules of 1 are linked through intermolecular N-H...N and N-H...O hydrogen bonds to form layers parallel to the ab plane. The molecules of 2 are linked through intermolecular C-H...Br hydrogen bonds to form a 3D network.     

Crystal structures of new isostructural oxovanadium(V) complexes with hydrazone ligands

Two new isostructural methoxide-bridged dimeric oxovanadium(V) complexes [VO(L¹)(OMe)]₂ (1) and [VO(L²)(OMe)]₂ (2), where L¹ and L² are the deprotonated forms of 3-bromo-N′-[1-(2-hydroxyphenyl)×ethylidene]benzohydrazide (H₂L¹) and 3-chloro-N′-[1-(2-hydroxyphenyl)ethylidene]benzohydrazide (H₂L²) respectively, are synthesized and characterized by elemental analyses, IR spectra, and single crystal X-ray determination. Both crystals crystallize in the triclinic space group P-1. For 1, a = 7.5237(15) Å, b = 10.846(3) Å, c = 11.195(3) Å, α = 84.143(3)°, β = 72.244(3)°, γ = 77.869(3)°, V = 849.9(4) ų, Z = 1, R ₁ = 0.0634, wR ₂ = 0.1373. For 2, a = 7.493(2) Å, b = 10.740(3) Å, c = 11.109(3) Å, α = 84.569(2)°, β = 71.783(2)°, γ = 79.822(2)°, V = 835.0(4) ų, Z = 1, R ₁ = 0.0511, wR ₂ = 0.1076. Each V atom in the complexes is octahedrally coordinated.     

Syntheses, crystal structures, and fluorescence properties of Zinc(II) complexes with multi-dentate Schiff bases

Two new structurally similar mononuclear Schiff base zinc(II) complexes, [ZnBr(ClMP)] (I) and [ZnCl(NMP)] (II) (ClMP = 4-chloro-2-[(3-morpholin-4-ylpropylimino)methyl]phenolate; NMP = 4-nitro-2-[(3-morpholin-4-ylpropylimino)methyl]phenolate), and two new dinuclear Schiff base zinc(II) complexes, [Zn₂(EMP)₂I₂] (III), and [Zn₂(MPA)(CH₃OH)₂(N₃)₂] (IV) (EMP = 5-diethylamino-2-[(2-dimethylaminoethylimino)methyl]phenolate; MPA = N,N′-bis(3-methoxysalicylidene)propane-1,3-diamine), have been prepared and characterized mainly by single-cyrstal X-ray diffraction. Complex I crystallizes in the monoclinic space group P2₁/n with unit cell dimensions: a = 15.116(3), b = 9.465(1), c = 23.714(4) Å, β = 104.358(2)°, V = 3286.9(8) ų, Z = 8, R ₁ = 0.0439, and wR ₂ = 0.0736. Complex II crystallizes in the monoclinic space group P2₁/c with unit cell dimensions: a = 7.253(2), b = 16.652(4), c = 13.568(3) Å, β = 96.600(2)°, V = 1627.8(6) ų, Z = 4, R ₁ = 0.0417, and wR ₂ = 0.0809. Complex III crystallizes in the monoclinic space group C2/c with unit cell dimensions: a = 27.962(2), b = 8.246(2), c = 31.605(3) Å, β = 90.343(2)°, V = 7287.4(15) ų, Z = 8, R ₁ = 0.0721, and wR ₂ = 0.1709. Complex IV crystallizes in the monoclinic space group C2/c with unit cell dimensions: a = 20.483(3), b = 11.344(2), c = 14.909(3) Å, β = 131.650(1)°, V = 2588.6(7) ų, Z = 4, R ₁ = 0.0343, and wR ₂ = 0.0792. Each Zn atom in I and II are four-coordinated in a tetrahedral geometry by the NNO donor set of the Schiff base ligand and one halide atom. The Zn atoms in III are in square pyramidal coordination, and those in IV are in octahedral and tetrahedral coordination. Thermal stability and fluorescence properties of the complexes I and II have also been determined.     

Synthesis,crystal structures,and biological property of dinuclear oxovanadium(V) complexes derived from tridentate Schiff bases

A pair of structurally similar dinuclear oxovanadium(V) complexes, [VO₂L¹]₂ (I) and [VO₂L²]₂ (II), where L¹ and L² are the mono-anionic form of 2-[(2-isopropylaminoethylimino)methyl]-4-methylphenol (HL¹) and 4-fluoro-2-[(2-isopropylaminoethylimino)methyl]phenol (HL²), respectively, have been synthesized and characterized by elemental analysis, FT-IR spectra, and single crystal X-ray determination. The crystal of I is monoclinic: space group P2₁/c, a = 12.528(1), b = 12.266(1), c = 9.432(1) Å, β = 104.814(3)°, V = 1401.2(3) ų, Z = 2. The crystal of I is monoclinic: space group P2₁/n, a = 12.3128(5), b = 6.5124(3), c = 17.1272(7) Å, β = 105.863(1)°, V = 1321.1(1) ų, Z = 2. The V…V distances are 3.210(1) Å in I and 3.219(1) Å in II. The V atoms in the complexes are in octahedral coordination. Biological assay indicates that complex II, bearing fluoro-substitute groups, has stronger antimicrobial activity against most bacteria than complex I which bearing methyl-substitute groups.     

Synthesis and structures of two hydrazone compounds derived from 4-methylbenzohydrazide

Two hydrazone compounds N′-(2,4-dichlorobenzylidene)-4-methylbenzohydrazide monohydrate (1) and 2-chloro-5-nitro-N′-(4-methylbenzylidene)benzohydrazide (2) derived from 4-methylbenzohydrazide with different benzaldehydes are synthesized and characterized by physicochemical methods and single crystal X-ray diffraction. Compound 1 crystallizes in the orthorhombic space group P2₁2₁2₁ with unit cell parameters a = 4.714(2) Å, b = 13.093(3) Å, c = 24.754(3) Å, V = 1527.9(8) ų, Z = 4, R ₁ = 0.0812, and wR ₂ = 0.1623. Compound 2 crystallizes in the monoclinic space group Cc with unit cell parameters a = 11.564(2) Å, b = 13.271(2) Å, c = 9.462(2) Å, β = 96.860(2)°, V = 1441.7(4) ų, Z = 4, R ₁ = 0.0461, and wR ₂ = 0.0896. The crystals of the compounds are stabilized by intermolecular hydrogen bonds as well as π…π stacking interactions.     

Crystal structures and antibacterial activity of hydrazone derivatives from 1H-indol-3-acetohydrazide

A series of three new hydrazone derivatives C₂₂H₁₉N₃O₂ (1), C₁₇H₁₃ClN₄O₃ (2), and C₂₁H₂₄N₄O₂·CH₄O (3) obtained by the condensation of ¹H-indol-3-acetohydrazide with 2-methoxynaphthaldehyde, 2-chloro-5-nitrobenzaldehyde, and 4-diethylaminosalicylaldehyde, respectively, in methanol, ia prepared. The compounds are characterized by elemental analysis, IR spectra, ¹H NMR spectra, and single crystal X-ray diffraction. Compound 1 crystallizes in the monoclinic space group P2₁/n with unit cell dimensions a = 17.740(2) Å, b = 5.621(1) Å, c = 18.573(3) Å, β = 92.659(2)°, V = 1850.0(6) ų, Z = 4, R ₁ = 0.0610 and wR ₂ = 0.1155. Compound 2 crystallizes in the monoclinic space group C2/c with unit cell dimensions a = 29.178(2) Å, b = 8.195(1) Å, c = 14.372(1) Å, β = 109.446(2)°, V = 3240.5(5) ų, Z = 8, R ₁ = 0.0452 and wR ₂ = 0.1028. Compound 3 crystallizes in the monoclinic space group Pc with unit cell dimensions a = 6.579(1) Å, b = 15.112(2) Å, c = 10.676(2) Å, β = 90.030(2)°, V = 1061.4(3) ų, Z = 2, R ₁ = 0.0535 and wR ₂ = 0.1123. The single crystal X-ray structural determination reveals that the molecules of the compounds are much twisted due to the lack of efficient conjugation. Preliminary biological tests indicate that the compounds are effective antibacterial material.     

Acid Co(II) and Ni(II) trifluoroacetate complexes: Synthesis and crystal structure

Anhydrous and partially hydrated acid trinuclear trifluoroacetates of divalent transition metals of the composition [M₃(CF₃COO)₆(CF₃COOH)₆)](CF₃COOH) and [M₃(CF₃COO)₆(CF₃COOH)₂(H₂O)₄)](CF₃COOH)₂, respectively, where M = Co (I, III) Ni (II, IV), were synthesized and studied by X-ray diffraction. Complexes I and II were obtained by crystallization from solutions of M(CF₃COO)₂ · 4H₂O in trifluoroacetic anhydride; complexes III and IV were synthesized under the same conditions with the use of 99% trifluoroacetic acid as a solvent. Crystals I are triclinic: space group $P\bar 1$ , a = 13.199(6) Å, b = 14.649(6) Å, c = 15.818(6) Å, α = 90.04(4)°, β = 114.32(4)°, γ = 108.55(4)°, V = 2611.3(19) ų, Z = 2, R = 0.0480. Crystals II are trigonal: space group $R\bar 3$ , a = 13.307(2) Å, c = 53.13(1) Å, V = 8148(2) ų, Z = 6, R = 0.1112. Crystals III are triclinic: space group $P\bar 1$ , a = 9.001(8) Å, b = 10.379(9) Å, c = 12.119(9) Å, α = 83.67(5)°, β = 72.33(5)°, γ = 83.44(5)°, V = 1068.3(15) ų, Z = 1 Å, R = 0.1031. Crystals IV are triclinic: space group $P\bar 1$ , a = 9.121(18) Å, b = 10.379(2) Å, c = 12.109(2) Å, α = 84.59(3)°, β = 72.20(3)°, γ = 82.80(3)°, V = 1080.94(40) ų, Z = 1, R = 0.0334.     

Characterization and crystal structures of solvated N′-(4-hydroxy-3-nitrobenzylidene)-3-methylbenzohydrazide and N′-(4-dimethyl-aminobenzylidene)-3-methylbenzohydrazide

Two new solvated benzohydrazone derivatives N′-(4-hydroxy-3-nitrobenzylidene)-3-methylbenzohydrazide-methanol-water (2/1/1) 2(C₁₅H₁₃N₃O₄)·CH₃OH·H₂O (1) and N′-(4-dimethylamino-benzylidene)-3-methylbenzohydrazide methanol monosolvate C₁₇H₁₉N₃O·CH₃OH (2) are prepared and characterized by elemental analysis, ¹H and ¹³C NMR, and single crystal X-ray diffraction. Compound 1 crystallizes in the monoclinic space group P2₁/c with unit cell dimensions a = 17.084(2) Å, b = 12.706(1) Å, c = 15.412(1) Å, β = 113.207(1)°, V = 3074.1(4) ų, Z = 4, R ₁ = 0.0567, and wR ₂ = 0.1209. Compound 2 crystallizes in the monoclinic space group P2₁/n with unit cell dimensions a = 15.058(1) Å, b = 6.658(1) Å, c = 17.211(2) Å, β = 94.189(2)°, V = 1720.8(3) ų, Z = 4, R ₁ = 0.0611, and wR ₂ = 0.1594. X-ray diffraction indicates that the asymmetric unit of 1 contains two independent benzohydrazone molecules, one methanol and one water molecules. The asymmetric unit of 2 contains one benzohydrazone molecule and one methanol molecule. Benzohydrazone molecules of the compounds display trans configurations with respect to the C=N double bonds. The crystal structures of the compounds are stabilized by hydrogen bonds and weak π...π interactions.     

Crystal and molecular structure of two new Schiff bases: Paeonol-ethylenediamine and paeonol-1,3-propylenediamine

Two new Schiff bases were prepared by the condensation reaction of paeonol with ethylenediamine (for compound 1) and 1,3-propylenediamine (for compound 2). The compounds were studied with single crystal X-ray diffraction method. Compound 1 is monoclinic, space group P2₁/c, a = 10.956(15) Å, b = 6.767(10) Å, c = 12.494(18) Å; β = 104.66(2)°, V = 896(2) ų, Z = 2. Compound 2 is triclinic, space group P-1, a = 6.878(2) Å, b = 12.141(4) Å, c = 12.414(4) Å; α = 101.023(6)°, β = 103.415(6)°, γ = 102.337(6)°, V = 952.8(6) ų, Z = 2. The molecular structures of 1 and 2 are similar; the molecule being centrosymmetric in 1 but asymmetric in 2.     

Crystal structure of two complexes containing tris-(β-diketonato)magnate anion

Single crystal XRD is used to determine the structures of the complexes (H₂TMEDA)[Mg(ptac)₃]₂ (1, TMEDA = Me₂N(CH₂)₂NMe₂, ptac = ^t BuCOCHCOCF₃) and (H₂TMEDA)[Mg(hfac)₃](hfac) (2, hfac = CF₃COCHCOCF₃) at a temperature of 150 K. The crystallographic data for complex 1: a = 10.2919(3) Å, b = 10.9492(4) Å, c = 15.4159(6) Å, α = 87.117(1)°, β = 89.686(1)°, γ = 79,864(1)°, space group $P\bar 1$ Z = 1, R = 0.0573; for complex 2: a = 12.9446(2) Å, b = 23.0035(4) Å, c = 13.1473(3) Å, β = 98.779(1)°, space group P2₁/n, Z = 4, R = 0.0605. The structures are ionic; the metal atom coordinates six oxygen atoms of three β-diketonate ligands. The distances Mg-O in complex 1 are in the range 2.036(2)–2.0920(19) Å; the same distances in complex 2 are in the range 2.051(2)–2.076(2) Å. The spatial packing is determined by the system of hydrogen bonds between the (H₂TMEDA)²⁺ cations and [Mg(ptac)₃]^? (1) or hfac^? (2) anions. A thermogravimetric study of complex 1 is carried out.     

New synthetic routes for the preparation of the triangular trinuclear clusters of tungsten-containing bromine atoms as terminal ligands: Structural characterization of [W3S4Br3(depe)3]PF6·0.5C7 H8 and [W3S4Br3(depe)3]Br·2CH3OH

Synthetic methods are reported for the preparation of compounds containing the trinuclear triangular cluster [W₃S₄Br₃(depe)₃[⁺. These involve reactions between WBr₅ and NaB(C₂ H₅)₃H or NaBH₄ as reducing agent in THF, and subsequent addition of methanolic solutions of NaHS and depe ligand. Both compounds, [W₃S₃Br₃(depe)₃]PF₆·0.5C₇H₈,1, and [W₃S₄Br₃(depe)₃]Br·2CH₃OH,2, are characterized by x-ray single crystal studies. Compounds1 and2 crystallize in space group \(P\bar 1\) . For1,a=10.427 (3) Å,b=15.415(4) Å,c=18.140(5) Å, α=79.36(2)°, β=73.59(2)°, γ=81.54(2)°, andV=2734.8(2) ų;R=0.050 and for 2a=10.491(3) Å,b=15.074(3) Å,c=18.246 Å, α=95.76(2)°, β=105.82(2)°, γ=98.18(2)°, andV=2718.4(3) ų;R=0.081. The two cations in1 and2 possess C₃ symmetry. The W-W distances are in the range 2.783?2.891 Å (for1) and 2.778?2.785 Å (for2) and the average W-Br distances in1 and2 are 2.616[2] Å and 2.594[4] Å, respectively. Each metal atom in the [W₃S₄Br₃(depe)₃]⁺ ions is attached to one capping sulfur atom, two bridging sulfur atoms, one bromine atom, and one chelating depe ligand. One P atom in depe ligand istrans to μ₃-S and the otherP atom istrans to a μ₂-S atom. UV-Vis and NMR spectra for these compounds are also reported.     

Oxidation of coordinated ethylenediamine in platinum(IV) complexes with bromine. Crystal structures of [Pt(en)Py2Br2]Br2 · H2O, [Pt(HN-C(O)-C(O)-NH)Py2Br2] · H2O, and [Pt(en)PyBr3]NO3

Heating of an aqueous solution of [Pt(en)Py₂Cl₂]Cl₂ · 2H₂O (I) with KBr excess leads to the formation of [Pt(en)Py₂Br₂]Br₂ · H₂O (II). The interaction of a solution of II with bromine water results in the precipitation of polybromide ([Pt(en)Py₂Br₂]Br₂ · Br₂), which within a few days in the reaction solution partly transforms into oximide platinum(IV) complex, [Pt(HN-C(O)-C(O)-NH)Py₂Br₂] · H₂O (III). Complex [Pt(en)PyBr₃]Br · H₂O (IV) with an impurity of II was prepared by reacting KBr excess and the product of [Pt(en)Py₂]Cl₂ oxidation with chlorine in 0.05 N HCl. The action of HNO₃ on the solution of IV produced a nitrate derivative ([Pt(en)PyBr₃]NO₃, V). Complex IV, unlike II, does not react with bromine. The IR spectra of all the obtained compounds were recorded. Complexes II, III, and V were studied by X-ray crystallography. The crystals of II are monoclinic, space group P2₁/c, a = 15.640(2) Å, b = 9.345(1) Å, c = 14.167(2) Å, β = 102.63(1)°, V = 2020.5(5) ų, Z = 4, R _hkl = 0.033. The crystals of III are triclinic, space group P $\bar 1$ , a = 7.108(1) Å, b = 10.946(1) Å, c = 11.020(2) Å, α = 83.63(1)°, β = 80.31(1)°, γ = 75.02(1)°, V = 814.4(2) ų, Z = 2, R _hkl = 0.033. In the near-planar five-membered chelate ring (torsion angle NCCN is 7°), the C-O distances (1.23(1) Å) correspond to double bonds; the C-C (1.53(1) Å) and C-N (1.31(1) Å), distances correspond to ordinary bonds. The crystals of V are monoclinic, space group P2₁/c, a = 8.306(2) Å, b = 8.995(2) Å, c = 20.231(4) Å, β = 97.48(2)°, V = 1498.6(6) ų, Z = 4, R _hkl = 0.037.     

Construction of chlorido-bridged dinuclear copper(II) complexes with similar tridentate Schiff bases

Two new chlorido-bridged dinuclear copper(II) complexes [Cu₂Cl₂(L¹)₂] (1) and [Cu₂Cl₂(L²)₂] (2), where L¹ and L² are the deprotonated form of Schiff bases 2-[1-(2-morpholin-4-ylethylimino)ethyl]phenol (HL¹) and 2-[1-(2-piperidin-1-ylethylimino)ethyl]phenol respectively, are prepared and structurally characterized by elemental analysis, IR spectra, and single crystal X-ray crystallography. Complex 1 crystallizes in the monoclinic space group P2₁/c with unit cell dimensions a = 8.0816(2) Å, b = 19.1780(3) Å, c = 9.6757(3) Å, β = 106.465(2)°, V = 1438.13(6) ų, Z = 2, R ₁ = 0.0409, and wR ₂ = 0.1085. Complex 2 crystallizes in the monoclinic space group P2₁/c with unit cell dimensions a = 7.7640(10) Å, b = 19.930(3) Å, c = 9.628(2) Å, β = 103.890(3)°, V = 1446.2(4) ų, Z = 2, R ₁ = 0.0634, and wR ₂ = 0.1316. Each Cu atom in the complexes is coordinated by three donor atoms of the Schiff bases and by two bridging Cl atoms, forming square pyramidal geometry. The Cl anions are preferred bridging groups for the construction of dinuclear copper complexes with tridentate Schiff bases.     

Crystal structures of 2-ferrocenylmethylidenehydrazono-1,3-dithiane and 2-ferrocenylmethylidenehydrazono-1,3-dithiepane

Two compounds of 2-ferrocenylmethylidenehydrazono-1,3-dithiane (1) and 2-ferrocenylmethylidenehydrazono-1,3-dithiepane (2) are synthesized and their single crystal structures are determined by the X-ray diffraction method. Compound 1 belongs to the orthorhombic Pca2₁ space group with the cell parameters: a = 13.989(4) Å, b = 5.785(2) Å, c = 18.231(5) Å, V = 1475.4(7) ų; while compound 2 crystallizes in a monoclinic symmetry, P2₁/c space group with a = 15.320(2) Å, b = 5.8028(6) Å, c = 36.584(4) Å, β = 91.932(1)° and V = 3250.4(6) ų.     

Syntheses and structures of mononuclear eight-coordinate Na[ErIII(Cydta)(H2O2]·5H2O (Cydta = trans-1,2-cyclohexanediaminetetraacetic acid) and binuclear nine-coordinate Na2[SmIII(Cydta)][SmIII(Cydta)(H2O)3] · 11H2O

The title complexes, Na[Er^III(Cydta)(H₂O)₂] · 5H₂O (I) and Na₂[Sm^III(Cydta)][Sm^III(Cydta)(H₂O)₃] · 11H₂O (II) (Cydta is trans-1,2-cyclohexanediaminetetraacetic acid), are prepared and characterized using IR, elemental analyses, and single-crystal X-ray diffraction techniques. Crystal I belongs to triclinic system (space group P1), which has a mononuclear eight-coordinate slightly distorted square antiprismatic conformation. The crystal data are as follows: a = 8.371(12) Å, b = 9.952(14) Å, c = 14.74(2) Å, α = 88.32(2)°, β = 76.30(2)°, γ = 87.87(2)°, V = 1192(3) ų, Z = 1, ρ = 1.835 g/cm³, μ = 3.612 mm^?1, F(000) = 658, R = 0.0194, and wR = 0.0520 for 4130 observed reflections with I≥2σ(I). Crystal II belongs to monoclinic system (space group P2₁/n), which has the binuclear nine-coordinate structure with tricapped trigonal prismatic conformation for Sm(1) and the pseudomonocapped square antiprismatic conformation for Sm(2). The crystal data are as follows: a = 12.283(6) Å, b = 15.626(7) Å, c = 25.875(12) Å, β = 97.962(7)°, V = 4919(4) ų, Z = 4, ρ = 1.717 g/cm³, μ = 2.476 mm^?1, F(000) = 2536, R = 0.0781, and wR = 0.1745 for 8554 observed reflections with I ≥ 2σ(I).     

Syntheses and crystal structures of [Ni(IIP)2] and [Cu2(PMP)2(μ1,1-N3)2] · MeOH (IIP = 2-iminomethyl-4,6-diiodophenolate, PMP = 2-[(2-phenylaminoethylimino)methyl]phenolate)

A new centrosymmetric mononuclear nickel(II) complex, [Ni(IIP)₂] (I), and a new end-on azido-bridged dinuclear copper(II) complex, [Cu₂(PMP)₂(μ_1,1-N₃)₂] · MeOH (II) (IIP = 2-iminomethyl-4,6-diiodophenolate, PMP = 2-[(2-phenylaminoethylimino)methyl]phenolate), have been prepared from similar tridentate Schiff bases derived from N-phenylethane-1,2-diamine with 3,5-diiodosalicylaldehyde and salicylaldehyde, respectively. The complexes were characterized by elemental analysis, infrared spectra, and single-crystal X-ray diffraction. Complex I crystallizes in the monoclinic space group P2₁/c with unit cell dimensions a = 4.936(1), b = 11.779(3), c = 15.789(4) Å, β = 90.722(3)°, V = 918.0(4) ų, Z = 2, R ₁ = 0.0267, and wR ₂ = 0.0546. Complex II crystallizes in the orthorhombic space group Pna2₁ with unit cell dimensions a = 23.370(2), b = 12.210(1), c = 11.438(1) Å, V = 3263.8(5) ų, Z = 4, R ₁ = 0.0461, and wR ₂ = 0.0891. The Ni atom in I is in a square planar coordination, and the Cu atoms in II are in square pyramidal coordination.     

A study of the structure and properties of mixed-ligand Cu(II) complexes with hexafluoroacetylacetone and methyl-, phenyl-ketoimines

The synthesis and X-ray single crystal study of two mixed-ligand Cu(II) complexes are performed: (CH₃C(NCH₃)CHC(O)CH₃)(CF₃C(O)CHC(O)CF₃)Cu (1) (space group P2₁/c, a = 7.0848(12) Å, b = 17.854(3) Å, c = 11.837(2) Å, β = 100.495(6)°, V = 1472.4(4) ų, Z = 4), (CH₃C(NC₆H₅)CHC(O)CH₃)· (CF₃C(O)CHC(O)CF₃)Cu (2) (space group P-1, a = 9.1119(4) Å, b = 9.6954(4) Å, c = 11.1447(6) Å, α = 113.784(2)°, β = 92.383(2)°, γ = 95.402(2)°, V = 893.52(7) ų, Z = 2). The structures are molecular, formed from neutral mixed-ligand copper complexes. The central copper atom has the (3O+N) coordination environment with average Cu-O distances of 1.948 Å and Cu-N of 1.932 Å; the chelate O-Cu-N angle (average) is 94.0°. In the structures, the complexes are linked into dimeric associates with Cu…Cu distances of 3.197 Å (for 1) and 3.246 Å (for 2). The volatility of mixed-ligand complexes 1 and 2 is in between of that of the starting homo-ligand complexes.     

Synthesis and crystal structure of lanthanum(III) Iodomercurate(II) complexes with ɛ-Caprolactam

The X-ray diffraction study of the crystalline products of the reaction between potassium tetraiodomercurate(II), ?-caprolactam, and lanthanum(III) nitrate at a ratio of 3: 16: 2 in an aqueous solution has shown the presence of the following three new crystalline compounds: [LaCpl₈]₂[HgI₄]₃ (I), [LaCpl₈][HgI₄]I₃ (II), and [LaCpl₇(H₂O)]₂[HgI₄]₂[Hg₂I₆] (III), where Cpl is ?-caprolactam ?-C₆H₁₁NO. Compounds I and II crystallize in tetragonal crystal system, space groups P4₂/n and $I\bar 4$ , respectively. For compound I, a = 18.59320(10) Å, c = 19.5782(3) Å, V = 6738.32(12) ų, Z = 2, and ρ_calc = 2.067 g/cm³. For compound II, a = 13.2245(10) Å, c = 20.0310(3) Å, V = 3503.17(6) ų, Z = 2, ρ_calc = 2.022 g/cm³. The crystals of compound III are monoclinic (space group P _{2 1}/n, a = 20.1202(6) Å, b = 14.0569(4) Å, c = 46.3228(12) Å, β = 93.4770(10)°, V = 13077.3(6) ų, Z = 4, ρ_calc = 2.274 g/cm³). [La(Cpl)₈]₂[Hg₂I₆]₃ (IV), a new double ionic complex salt, has also been synthesized and studied by X-ray diffraction. The crystals of compound IV are triclinic (space group $P\bar 1$ , a = 12.5021(3) Å, b = 14.6436(3) Å, c = 21.4695(4) Å, α = 84.2300(10)°, β = 87.2230(10)°, γ = 74.9970(10)°, V = 3776.30(14) ų, Z = 1, ρ_calc = 2.452 g/cm³). All complexes have a dicrete ionic structure, and the nearest surrounding of a La atom is distorted square-prismatic or trigonal-dodecahedral. The crystal packing of cations is distorted face-centered cubic (I and II) or body-centered cubic (III and IV) with anions located in its cavities.     

Synthesis,structures, and antibacterial activity of Schiff-base cobalt(III) complexes

Two new Schiff-base cobalt(III) complexes, [CoL¹(En)N₃]Cl (I) and [CoL²N₃(OH₂)] (II), where L¹, L², and En are 2-[1-(2-aminoethylimino)ethyl]phenolate, bis(5-chlorosalicylidene)ethane-1,2-diamine, and 1,2-ethylenediamine, respectively, have been prepared and characterized by physicochemical methods and single crystal X-ray determination. Complex I crystallizes in monoclinic system space group P2₁/n with a = 7.113(1), b = 21.385(1), c = 10.599(1) Å, β = 106.067(2)°, V = 1549.2(3) ų, Z = 4, R ₁ = 0.0322, and wR ₂ = 0.0800. Complex II crystallizes in monoclinic system space group P2₁/c with a = 1.679(1), b = 11.145(1), c = 12.493(1) Å, β = 110.553(2)°, V = 1783.5(2) ų, Z = 4, R ₁ = 0.0360, and wR ₂ = 0.0838. Single crystal X-ray diffraction analysis reveals that the Co atoms in the complexes are six-coordinated in octahedral geometry. The complexes were screened in vitro for their antibacterial activity against Bacillus subtillis, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.     

Synthesis and study of tetraamminecobalt hydrogen hexamolybdometalates(III)

Tetraamminecobalt hydrogen hexamolybdoferrate [Co(NH₃)₄] · H[FeMo₆O₁₈(OH)₆] · 6H₂O (I) and tetraamminecobalt hydrogen hexamolybdogallate(III) [Co(NH₃)₄] · H[GaMo₆O₁₈(OH)₆] · 6H₂O (II) were synthesized and studied by mass spectrometry, thermogravimetry, IR spectroscopy, and X-ray diffraction. Crystals of I and II are monoclinic; a = 16.21 Å, b = 5.43 Å, c = 12.32 Å, β = 119.63°, V = 1092.11 ų, ρ_calcd = 2.21 g/cm³, and Z = 1 for I; a = 16.24 Å, b = 5.59 Å, c = 12.29 Å, β = 119.79°, V = 1064.05 ų, ρ_calcd = 2.15 g/cm³, and Z = 1 for II. Compounds I and II were used as catalysts for soft oxidation of natural gas.